Readiness in reality: event report

Readiness in reality: event report

What is being done to get ready for radioligand therapy? This question was the focus of the ‘Readiness in reality: activities supporting the future of radioligand therapy’ even
Read More
HPP presents at European Health Management Association webinar on fostering health system resilience

HPP presents at European Health Management Association webinar on fostering health system resilience

HPP presented as part of the EHMA’s webinar ‘Towards future-readiness: measuring health systems’ resilience’.
Read More
‘Readiness in reality: activities supporting the future of radioligand therapy’ – register now

‘Readiness in reality: activities supporting the future of radioligand therapy’ – register now

HPP warmly invites you to 'Readiness in reality: activities supporting the future of radioligand therapy'. This free online event will take place on 17 November 2022.
Read More
Introducing the UK Molecular Radiotherapy Consortium

Introducing the UK Molecular Radiotherapy Consortium

The UK Molecular Radiotherapy Consortium is an alliance of clinicians and patient advocates formed to support equitable access to evidence-based theranostic MRT across the UK.
Read More
New masterclass video to support application of the Readiness Assessment Framework

New masterclass video to support application of the Readiness Assessment Framework

HPP has developed a masterclass video which explains how to apply the Readiness Assessment Framework.
Read More
HPP launches framework to assess health system readiness

HPP launches framework to assess health system readiness

HPP is pleased to launch the Readiness Assessment Framework, which can be used to assess health system readiness for a number of different components of care.
Read More
Call to share experiences of integrating radioligand therapy into care

Call to share experiences of integrating radioligand therapy into care

The Health Policy Partnership wants to better understand what actions and initiatives have taken place to improve the delivery of radioligand therapy.
Read More
SPARC-Europe highlights patient experience of radioligand therapy in new video

SPARC-Europe highlights patient experience of radioligand therapy in new video

SPARC-Europe has released a video of patient testimonies to raise awareness of the benefits of radioligand therapy and outline some of the challenges to access.
Read More
New templates to aid application of the Radioligand Therapy Readiness Assessment Framework

New templates to aid application of the Radioligand Therapy Readiness Assessment Framework

The Health Policy Partnership has published a series of templates to support independent applications of the Radioligand Therapy Readiness Assessment Framework.
Read More
ASH 2021 poster focuses on uptake of radioimmunotherapy for lymphoma

ASH 2021 poster focuses on uptake of radioimmunotherapy for lymphoma

The Health Policy Partnership has published a poster at the 63rd annual meeting of the American Society of Hematology (ASH).
Read More
Leading experts join HPP and Avalere to examine readiness for radioligand therapy in the US

Leading experts join HPP and Avalere to examine readiness for radioligand therapy in the US

The Health Policy Partnership (HPP) and Avalere Health recently held a webinar on the use of radioligand therapy and readiness for its future integration in the US.
Read More
HPP launches policy brief at an event coinciding with ESMO 2021

HPP launches policy brief at an event coinciding with ESMO 2021

HPP was thrilled to launch its new policy brief 'Fostering system readiness in cancer care' on 21 September 2021, at an event coinciding with ESMO 2021.
Read More